Dr. Oriol Mitjà receives a grant from the European Research Council to develop a vaccine against syphilis
04/12/2024
A study led by Dr. Silvia Roure, head of the International Health and Neglected Diseases section of the Fight Infections Foundation, and Dr. Cristina Vilaplana of the Experimental Tuberculosis Unit, observes a considerable increase in the number of serious cases of tuberculosis in the metropolitan area of Barcelona during the period 2019-2021. This trend may reflect the impact of the COVID-19 pandemic, which coincided with a substantial reduction in diagnostic tests for this infection and subsequent access to health services. Research confirms that the migrant population residing in low-income areas has a higher prevalence of presenting severe clinical forms.
Tuberculosis is still a global public health problem that affects millions of people in the world, predominantly in countries where the income level is low or medium, but it also becomes a threat to the public health of countries. with a high level of income. Despite significant progress in recent decades, it is estimated that in 2016 in the world there were a total of 10.4 million people who contracted the disease, of which 1.6 million (16%) died. Of the people affected by tuberculosis, 90% were men, 10% were previously infected with HIV and 56% of the cases were located in five countries: India, Indonesia, China, the Philippines and Pakistan.
Disseminated tuberculosis
Disseminated tuberculosis is a severe form of tuberculosis in which Mycobacterium tuberculosis infection spreads throughout the body through the bloodstream and manifests itself by affecting two or more organs. Instead of being confined to the lungs, as in the typical pulmonary form of tuberculosis, the bacteria spread to other organs and tissues, such as the liver, kidneys, spleen, brain, and bones.
The study «Disseminated tuberculosis and diagnosis delay during the COVID-19 era in a Western European country: a case series analysis» presents a detailed analysis of a set of patients with disseminated tuberculosis who were diagnosed in the metropolitan area of Barcelona, from 2019 before the start of the COVID-19 pandemic, until the end of 2021. The research finds an increase in tuberculosis cases disseminated in the pandemic and post-pandemic context, coinciding with a notable diagnostic delay. The study aims to examine the link between delay in diagnosis and presentation of disseminated tuberculosis, to determine the underlying risk factors and to perform a detailed analysis of the clinical, imaging and laboratory findings of this form of tuberculosis.
Increase in tuberculosis cases
The study contemplates a retrospective analysis of all new cases of disseminated tuberculosis diagnosed at the Germans Trias i Pujol University Hospital in Badalona, from January 2019 to December 2021. This is the reference hospital for the Northern Crown of the Metropolitan Area of Barcelona. with 406,000 inhabitants. Immigrants make up approximately 17% of the population. For all patients diagnosed with disseminated tuberculosis, sociodemographic, clinical, and laboratory data were collected, including patient age, sex, body mass index (BMI), country or region of origin, current household location, and primary and secondary foci of tuberculosis in diagnosis and laboratory and imaging results. Additionally, the date of the first contact with the health system in which symptoms compatible with the initial focus of tuberculosis were diagnosed and the number of visits between the first symptoms recorded and the final diagnosis of the infection were noted.
The migrant population most susceptible to infection
Conclusion
04/12/2024
12/09/2024
29/08/2024
Share